Icosavax is based in Seattle. It has raised $51M in total funding. Latest round: Series A.
Icosavax funding overview
Icosavax is based in Seattle. Icosavax has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2019. The round record for Icosavax runs through 2019; nothing later has been disclosed. Investors on record include Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors and 1 others. 7 distinct backers are named across the disclosed rounds.
Icosavax at a glance
Total raised
$51M
Latest round
Series A
Latest round date
January 2019
Headquarters
Seattle
Notable investors
Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors, Perceptive Advisors
Frequently asked about Icosavax funding
How much has Icosavax raised?
Icosavax has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Icosavax?
Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors are named among the investors backing Icosavax.
What was the latest Icosavax funding round?
The most recent disclosed round is a Series A, announced in January 2019.
Where is Icosavax based?
Icosavax is based in Seattle.
When did Icosavax last raise?
The last disclosed Icosavax round closed in January 2019 at Series A.
Totals shown for Icosavax aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
